Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Genesys Capital is a life sciences venture capital firm founded in 2000 and headquartered in Toronto, Canada. The firm specializes in investing in early-stage life sciences companies, utilizing a robust scientific network and partnerships with leading research institutes and universities to facilitate medical advancements. Over the years, Genesys has raised more than $400 million across five venture funds, establishing a significant presence in the North American investment landscape.
Currently, Genesys Capital manages a portfolio of 44 companies, reflecting its commitment to fostering innovation in the healthcare sector. The firm’s strategic focus on collaboration with scientific founders and entrepreneurs positions it as a key player in driving breakthroughs in medical technology and biotechnology.
Genesys Capital exclusively invests in early-stage life sciences companies, targeting funding stages from pre-seed to Series A. The firm’s investment strategy emphasizes collaboration with scientific founders and entrepreneurs, aiming to create and develop innovative healthcare solutions. Their geographic focus is primarily on North America, particularly Canada, where they leverage local expertise and networks.
Investment checks typically range from $500,000 to $5 million, allowing for flexibility in supporting startups at various stages of their development. Genesys Capital seeks companies that demonstrate strong scientific foundations and the potential for significant impact in the biotech and healthcare sectors.
Genesys Capital's portfolio includes notable companies such as:
These companies exemplify Genesys Capital's focus on innovative healthcare solutions and successful exits, showcasing the firm's ability to identify and nurture high-potential startups in the life sciences sector.
Jennifer Williams: Partner and Chief Financial Officer, brings extensive financial expertise from her previous roles in venture capital and investment banking.
Damian Lamb: Co-founder and Managing Director, has a strong background in life sciences and has led numerous successful investments in the sector.
Lisa Low: Senior Vice President of Finance, responsible for financial strategy and operations, with a background in corporate finance.
Kelly Holman: Co-founder and Managing Director, has significant experience in venture capital and a deep understanding of the biotech landscape.
Sarah Farr: Principal, focuses on sourcing and evaluating investment opportunities in the life sciences sector.
Jamie Stiff: Managing Director, brings expertise in operational management and strategic growth for portfolio companies.
Christine Thoburn: Office Manager, oversees administrative functions and supports the team in daily operations.
To pitch Genesys Capital, founders should use the contact form on their website or email info@genesyscapital.com. A comprehensive pitch deck is essential, detailing the startup's vision, market analysis, and team qualifications. Response times may vary, but founders should expect to hear back within a few weeks.
In recent months, Genesys Capital has continued to expand its portfolio, focusing on innovative life sciences companies. Notable investments include new funding rounds for existing portfolio companies, enhancing their capabilities in the healthcare sector.
The firm has also been active in discussions with potential new investments, seeking to identify promising startups that align with their investment thesis. Their commitment to early-stage life sciences remains strong, as they aim to drive medical breakthroughs through strategic partnerships and funding.
What criteria does Genesys Capital use for investments?
Genesys Capital invests in early-stage life sciences companies, focusing on those with strong scientific foundations and innovative healthcare solutions. They target pre-seed to Series A stages and prefer to collaborate with scientific founders.
How can I pitch to Genesys Capital?
Founders can pitch Genesys Capital through their website at genesyscapital.com or by emailing info@genesyscapital.com. A detailed pitch deck outlining the business model, market opportunity, and team is recommended.
What makes Genesys Capital different from other VCs?
Genesys Capital emphasizes collaboration with scientific innovators and has a strong network within the life sciences sector. Their focus on early-stage investments allows them to work closely with founders to drive medical breakthroughs.
What is the typical check size for investments?
Genesys Capital typically invests between $500,000 and $5 million in early-stage companies, providing the necessary capital to support growth and development.
What is the geographic focus of Genesys Capital?
The firm primarily invests in North America, with a strong emphasis on opportunities within Canada, leveraging local expertise and networks to identify promising startups.
What kind of support do portfolio companies receive?
Genesys Capital provides operational support, strategic guidance, and access to their extensive network of scientific and industry contacts, helping portfolio companies navigate challenges and accelerate growth.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.